Profil
Yong Xiang Wang currently works at Sirnaomics Ltd., as Chief Production Officer from 2024.
Dr. Wang also formerly worked at NewLink Genetics Corp., as Director-Vaccine Production from 2014 to 2016, Aeras Global TB Vaccine Foundation, as Deputy Director-Engineering from 2007 to 2011, Charter Medical Ltd., as Technology Director from 2005 to 2006, Ben Venue Laboratories, Inc., as Technology Consultant-Parexel International from 2011 to 2012, WuXi AppTec Co., Ltd., as Vice President-Technical Operations from 2012 to 2014, and Shanghai Furen Medicine R&D Co., Ltd., as Deputy General Manager from 2016 to 2018.
Dr. Wang received his undergraduate degree in 1976 from the University of Science & Technology of China, graduate degree in 1983 from Tokyo Institute of Technology, and doctorate degree in 1995 from Aalto University School of Science & Technology.
Postes actifs de Yong Xiang Wang
| Sociétés | Poste | Début |
|---|---|---|
| SIRNAOMICS LTD. | Corporate Officer/Principal | 15/12/2021 |
Anciens postes connus de Yong Xiang Wang
| Sociétés | Poste | Fin |
|---|---|---|
Shanghai Furen Medicine R&D Co., Ltd. | Corporate Officer/Principal | 01/06/2018 |
| LUMOS PHARMA, INC. | Corporate Officer/Principal | 01/06/2016 |
| WUXI APPTEC CO., LTD. | Corporate Officer/Principal | 01/02/2014 |
Ben Venue Laboratories, Inc.
Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures sterile liquid products | Corporate Officer/Principal | 01/10/2012 |
Aeras Global TB Vaccine Foundation
Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Corporate Officer/Principal | 01/10/2011 |
Formation de Yong Xiang Wang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
NewLink Genetics Corp.
NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
Aeras Global TB Vaccine Foundation
Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Commercial Services |
Ben Venue Laboratories, Inc.
Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures sterile liquid products | Health Technology |
University of Science & Technology of China
University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tokyo Institute of Technology
Tokyo Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products & medical devices | Health Technology |
Charter Medical Ltd.
Charter Medical Ltd. BiotechnologyHealth Technology Specializes in the design and supply of biologic fluids in biotech and clinical applications | Health Technology |
Aalto University School of Science & Technology
Aalto University School of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sirnaomics Ltd.
Sirnaomics Ltd. BiotechnologyHealth Technology Develops therapeutics for treatment of cancer and fibrosis diseases | Health Technology |
Shanghai Furen Medicine R&D Co., Ltd. |
















